Skip to Content

Exclusive to

SiloxysSystem™

Advanced topical gel for precision-targeted delivery

Abstract waves background image
Precisely targets finasteride to the hair follicles
Precisely targets finasteride to the hair follicles
Limits finasteride absorption into the bloodstream
Limits finasteride absorption into the bloodstream
Designed to maximize hair growth and minimize side effects
Designed to maximize hair growth and minimize side effects
XYON’s exclusive gel technologyDesigned to perform
1
2
3
4
XYON’s exclusive gel technology diagram
1
Compounded with finasteride into timed-release SiloxysSystem™ gel nanoparticles
2
Slowly and steadily delivers finasteride precisely to the hair follicles
3
Lowers the hormone DHT at the scalp, the leading cause of hair loss in men
4
Inhibits absorption of finasteride into the bloodstream compared with oral and other topical formulations
A sample of XYON topical finasteride in a petri dish
An advanced topical formulation

Most topical hair loss treatments that deliver finasteride through the skin are unintentionally absorbed into the bloodstream. SiloxysSystem’s™ lipid-based nanoparticles are suspended in a slow-releasing matrix that concentrates finasteride directly at the hair follicles where it's needed to target hair loss.

Knowledge that matters. Science that works.

Performance without compromise

Only with XYON.
Start your free consultation
Man holding a can of XYON's topical finasteride
Dr. Victor Hasson talking to a patient
A will to innovate and a lifetime of experience

A leading pioneer in hair restoration, Dr. Victor Hasson developed SiloxysSystem™ in his practice as a clinician to unlock the full potential of finasteride in combating hair loss while minimizing the negative side effects of oral use. Combined with Dr. Simon Pimstone’s experience and passion for innovative medical solutions, XYON’s goal of helping men look, live, and feel their absolute best was born.

Our vision

Defy the norm.

About 50% of men experience some degree of hair loss by the age of 50*. *Pirastu et al., Nature.
Start your free consultation
Man holding a can of XYON's topical finasteride

Stay in the Know

Be among the first to learn about exciting exclusive offers and the latest treatment news.

© 2022 XYON Health Inc. All rights reserved.

This webpage is intended only for residents of the United States.